Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older AdultsDiabetes Care 2021 Jan 25;[EPub Ahead of Print], E Patorno, A Pawar, LG Bessette, DH Kim, C Dave, RJ Glynn, MN Munshi, S Schneeweiss, DJ Wexler, SC Kim
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.